CytoDyn Inc.
Public company- Headquarters
- VANCOUVER, Washington
- Ticker
- CYDY
- CIK
- 0001175680
WARN notices since 2024
Workers affected since 2024
Executive changes, last 12 months
Last event
Workers affected over time
Cumulative workers in WARN notices since 2024
Not enough notices to chart yet.
Leadership
| Role and person | Since | Change |
|---|---|---|
| CEORobert E. Hoffman | Oct 19, 2026 | Appointed |
Related companies
Same industry and state, with recent events.
- OMEROS CORP
director appointed: Joseph Schocken
- BRISTOL MYERS SQUIBB CO
WARN notice: Princeton, NJ
- JOHNSON & JOHNSON
WARN notice: New Brunswick, NJ
- Merck & Co., Inc.
WARN notice: Rahway, NJ
- Executive appointment
CEO appointed: Robert E. Hoffman
Robert E. Hoffman was named Chief Executive Officer of CytoDyn Inc., effective October 20, 2026. Robert E. Hoffman succeeds Jacob P. Lalezari, M.D.. The company reported the change in an 8-K that cites Item 5.02.
Source: SEC 8-K, filed Oct 19, 2026Role: Chief Executive Officer
- Executive departure
CEO departs: Jacob P. Lalezari, M.D.
Jacob P. Lalezari, M.D., Chief Executive Officer of CytoDyn Inc., resigns the role, effective October 20, 2026. The company reported the change in an 8-K that cites Item 5.02.
Source: SEC 8-K, filed Oct 19, 2026Role: Chief Executive Officer
Last verified Nov 8, 2026